Given that these lesions are more common in women than men and that the rate decreasesafter menopause, sex steroid hormones are thought to play a role in the etiology of the benign and malignant lesions of the thyroid. .Conclusion: The findings in our study support many studies in the literature, and there is a significant relationship between tumorsize, tumor stage, and metastasis and ERα and PR immunohistochemical expression.However, more studies are still needed toevaluate the effect of ERα and PR on thyroid papillary cancers.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Aim: Estrogen receptor-α(ERα) and Progesterone receptor(PR) were studied in 58 patients who were diagnosed as papillary thyroidcarcinoma in our hospital between 2011 and 2013.ERα and PR expression patterns were compared according to age, sex, tumorsubtype, metastasis, focality and tumor size.Material and Methods: ERα and PR immunohistochemical staining were performed on a Ventana Benchmark XT device.More than10% expression of ERα and PR immunohistochemical stains in the tumor field was considered positive.Results: Papillary thyroid cancer is the most common type of endocrine malignancy in females and it is approximately three timesmore common among females than males.
📊
Key Findings & Data:Aim: Estrogen receptor-α(ERα) and Progesterone receptor(PR) were studied in 58 patients who were diagnosed as papillary thyroidcarcinoma in our hospital between 2011 and 2013.ERα and PR expression patterns were compared according to age, sex, tumorsubtype, metastasis, focality and tumor size.Material and Methods: ERα and PR immunohistochemical staining were performed on a Ventana Benchmark XT device.More than10% expression of ERα and PR immunohistochemical stains in the tumor field was considered positive.Results: Papillary thyroid cancer is the most common type of endocrine malignancy in females and it is approximately three timesmore common among females than males.
💡
Conclusion & Impact:Given that these lesions are more common in women than men and that the rate decreasesafter menopause, sex steroid hormones are thought to play a role in the etiology of the benign and malignant lesions of the thyroid. .Conclusion: The findings in our study support many studies in the literature, and there is a significant relationship between tumorsize, tumor stage, and metastasis and ERα and PR immunohistochemical expression.However, more studies are still needed toevaluate the effect of ERα and PR on thyroid papillary cancers.
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters
Abstract
Aim: Estrogen receptor-α(ERα) and Progesterone receptor(PR) were studied in 58 patients who were diagnosed as papillary thyroidcarcinoma in our hospital between 2011 and 2013.ERα and PR expression patterns were compared according to age, sex, tumorsubtype, metastasis, focality and tumor size.Material and Methods: ERα and PR immunohistochemical staining were performed on a Ventana Benchmark XT device.More than10% expression of ERα and PR immunohistochemical stains in the tumor field was considered positive.Results: Papillary thyroid cancer is the most common type of endocrine malignancy in females and it is approximately three timesmore common among females than males. Given that these lesions are more common in women than men and that the rate decreasesafter menopause, sex steroid hormones are thought to play a role in the etiology of the benign and malignant lesions of the thyroid. .Conclusion: The findings in our study support many studies in the literature, and there is a significant relationship between tumorsize, tumor stage, and metastasis and ERα and PR immunohistochemical expression.However, more studies are still needed toevaluate the effect of ERα and PR on thyroid papillary cancers.
🔖
Cite This Article
CENGİZ, B. P. (2022). The importance of estrogen-α and progesterone immunohistochemical staining expression in patients with papillary thyroid carcinoma. Annals of Medical Research, Cilt: 26 - Sayı: 10, 2143–2147. https://ajindex.com/articles/447155
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7-34
Tavangar SM, Monajemzadeh M, Larijani B, et al. Immunohistochemical study of oestrogen receptors in 351 human thyroid glands. Singapore Med J 2007;48:744-7
Tomikawa J, Homma T, Tajima S, et al. Molecular Characterization and Estrogen Regulation of Hypothalamic KISS1 Gene in the Pig Bio. Reprod 2009
Fadini GP, Albiero M, Cignarella A, et al. Effects of androgens on endothelial progenitor cells in vitro and in vivo. Clin Sci (Lond) 2009;117:355-64
Kumar DM, Simpkins JW, Agarwal N. Estrogens and neuroprotection in retinal diseases. Mol Vis 2008;14:1480- 86
Isgor C, Watson SJ. Estrogen receptor alpha and beta mRNA expressions by proliferating and differentiating cells in the adult rat dentate gyrus and subventricular zone. Neuroscience 2005;134:847-56
Kelly MJ, Rønnekleiv OK. Control of CNS neuronal excitability by estrogens via membrane-initiated signaling. Mol Cell Endocrinol 2009;308:17-25
Galea LA. Gonadal hormone modulation of neurogenesis in the dentate gyrus of adult male and female rodents. Brain Res Rev 2008;57:332-41
Prange-Kiel J, Rune G.M. Direct and indirect effects of estrogen on rat hippocampus. Neuroscience 2006;138:765- 72
Kuiper GG, Shughrue PJ, Merchenthaler I, et al. The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems. Front Neuroendocrinol 1998;19:253-86
Matthews J, Gustafsson JA. Estrogen signaling: A subtle balance between ER alpha and ER beta. Mol Interv 2003;3:281-92
Zhao C, Dahlman-Wright K, Gustafsson JA. Estrogen receptor beta: An overview and update. Nucl Recept. Signal 2008;6:3 13. Katzenellenbogen BS, Choi I, Delage-Mourroux R, et al.Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology. J. Steroid Biochem. Mol. Biol 2000;74:279-85
Lindberg MK, Movérare S, Skrtic S, et al. Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a “ying yang” relationship between ERalpha and ERbeta in mice. Mol Endocrinol 2003;17:203-8
Monroe DG, Getz BJ, Johnsen SA, et al. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta. J Cell Biochem 2003;90:315-26
Cheung E, Schwabish MA, Kraus WL. Chromatin exposes intrinsic differences in the transcriptional activities of estrogen receptors alpha and beta. E.M.